Multidisciplinary management of TNBC Integrating immunotherapies for early and metastatic disease
touchEXPERT FOCUS for touchONCOLOGY
Listen to a series of short interviews with three leading experts discussing the application of immunotherapy in triple-negative breast cancer (TNBC). The experts explore the latest data and guideline recommendations for immunotherapy in early-stage and metastatic TNBC, and how to maximize treatment benefits.
The experts:
Prof. Sherko Kümmel – Kliniken Essen-Mitte, Essen, Germany
Prof. Rebecca Dent – National Cancer Center Singapore, Singapore
Prof. Peter Schmid – Barts Cancer Institute, London, UK
This touchPODCAST is for healthcare professionals outside…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.